TRI-IODOTHYROACETIC ACID (TRIAC) (Emcitate®)

Clinical Indication

Allan-Herndon Dudley syndrome associated with MCT-8 deficiency

Comments

Reviewed by TAS 22nd June 2021

Date of classification

July 2021

Review date

July 2021

Black

Drugs not recommended for use in the Leicestershire Health Community because of lack of evidence of clinical effectiveness, cost prioritization or concerns over safety.

All new drugs will be black until they have been through the appropriate approval process - then they will appear as a specific entry.